The Biden administration on Thursday retracted a Trump-era rule that would have required community health centers to pass all insulin and epinephrine discounts to patients or lose federal grant money.
Biden’s Health and Human Services Department withdrew the rule “due to the excessive administrative costs and burdens that implementation would have imposed on health centers,” the agency said in a Federal Register filing (RIN 0906-AB30).
The Trump-era rule (RIN 0906-AB25) was finalized right before former President Donald Trump left office. Health officials said the intent of the rule was to make it easier for low-income patients to afford ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.